Ritonavir-boosted protease inhibitor monotherapy is 6% less effective than combination antiretroviral therapy in a meta-analysis

Detalles Bibliográficos
Autores principales: Bierman, WFW, Humphreys, EH, van Agtmael, MA, Boucher, CA, Rutherford, GW
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2010
Materias:
Oral Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112830/
http://dx.doi.org/10.1186/1758-2652-13-S4-O18
_version_ 1782205826953379840
author Bierman, WFW
Humphreys, EH
van Agtmael, MA
Boucher, CA
Rutherford, GW
author_facet Bierman, WFW
Humphreys, EH
van Agtmael, MA
Boucher, CA
Rutherford, GW
author_sort Bierman, WFW
collection PubMed
description
format Online
Article
Text
id pubmed-3112830
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-31128302011-06-13 Ritonavir-boosted protease inhibitor monotherapy is 6% less effective than combination antiretroviral therapy in a meta-analysis Bierman, WFW Humphreys, EH van Agtmael, MA Boucher, CA Rutherford, GW J Int AIDS Soc Oral Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3112830/ http://dx.doi.org/10.1186/1758-2652-13-S4-O18 Text en Copyright ©2010 Bierman et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oral Presentation
Bierman, WFW
Humphreys, EH
van Agtmael, MA
Boucher, CA
Rutherford, GW
Ritonavir-boosted protease inhibitor monotherapy is 6% less effective than combination antiretroviral therapy in a meta-analysis
title Ritonavir-boosted protease inhibitor monotherapy is 6% less effective than combination antiretroviral therapy in a meta-analysis
title_full Ritonavir-boosted protease inhibitor monotherapy is 6% less effective than combination antiretroviral therapy in a meta-analysis
title_fullStr Ritonavir-boosted protease inhibitor monotherapy is 6% less effective than combination antiretroviral therapy in a meta-analysis
title_full_unstemmed Ritonavir-boosted protease inhibitor monotherapy is 6% less effective than combination antiretroviral therapy in a meta-analysis
title_short Ritonavir-boosted protease inhibitor monotherapy is 6% less effective than combination antiretroviral therapy in a meta-analysis
title_sort ritonavir-boosted protease inhibitor monotherapy is 6% less effective than combination antiretroviral therapy in a meta-analysis
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112830/
http://dx.doi.org/10.1186/1758-2652-13-S4-O18
work_keys_str_mv AT biermanwfw ritonavirboostedproteaseinhibitormonotherapyis6lesseffectivethancombinationantiretroviraltherapyinametaanalysis
AT humphreyseh ritonavirboostedproteaseinhibitormonotherapyis6lesseffectivethancombinationantiretroviraltherapyinametaanalysis
AT vanagtmaelma ritonavirboostedproteaseinhibitormonotherapyis6lesseffectivethancombinationantiretroviraltherapyinametaanalysis
AT boucherca ritonavirboostedproteaseinhibitormonotherapyis6lesseffectivethancombinationantiretroviraltherapyinametaanalysis
AT rutherfordgw ritonavirboostedproteaseinhibitormonotherapyis6lesseffectivethancombinationantiretroviraltherapyinametaanalysis

Ejemplares similares